Podcasts about iu health

Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book.  Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer.  On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode.  Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited.  While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results.  And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this.  Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas.  On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes.  Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program.  In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system.  In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense.  So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers.  We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer.  We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost.  In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer.  So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future.  A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology.  We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode.  Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:     Dr. Nathan Pennell    @n8pennell   @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media:     @ASCO on X (formerly Twitter)     ASCO on Bluesky    ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Nate Pennell:        Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron       Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi    Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics

Inside INdiana Business Radio for the afternoon of June 9, 2025. The Evansville Vanderburgh School Corp. breaks ground on its new Innovation Center for Science and Health. Plus, IU Health is facing a discrimination lawsuit. Get the latest business news from throughout the state at InsideINdianaBusiness.com.

U.S. Representative André Carson is seeking information on how an Indiana military base could potentially be used as an immigration detention center. A former administrator of two now-closed Indiana virtual charter schools has agreed to plead guilty in a multi-million dollar fraud case. Indiana is bringing back A-to-F letter grades for schools – but what happens to schools that fail in the system?  A paramedic at IU Health is suing the hospital system, claiming he was harassed and retaliated against because of his sexual orientation. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Drew Daudelin, Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

Inside INdiana Business Radio for the morning of June 5, 2025. Indiana Golf has opened its new headquarters and Hall of Fame at the Fort Golf Resort in Indianapolis. IU Health's $4.3 billion downtown hospital campus remains on time and on budget. Also: Huntington faces 62 layoffs as General Aluminum shuts down, bankruptcy filings are rising, and efforts to improve traffic safety continue with expanded Road to Zero programs. Get the latest business news from throughout the state at InsideINdianaBusiness.com.

Tonight, on Trackside with Curt Cavin and Kevin Lee, it’s the 2025 Burger Bash! They start the show joined by Callum Ilott as he talks about being with Prema Racing for the Indy 500. They are later joined by James Hinchcliffe and Conor Daly as they talk about their race predictions and how Conor has performed this week. They are then joined by Santino Ferrucci and Ryan Hunter-Reay to talk about how their practice went today. To wrap up the first segment, they are joined by polesitter for the 109th Indianapolis 500, Robert Shwartzman to recap his qualifying run and talk with Jack Harvey on his 500 week. In the second segment of the show, Curt and Kevin are joined by Sting Ray Robb and Kyffin Simpson to recap their Monday practice. Then to wrap up the first hour of the show, they are joined by Bob Pockrass to talk about him living in Indiana and covering IndyCar and NASCAR. In the second hour of the show, Curt and Kevin announce that the 109th Indianapolis 500 is officially sold out! They then are joined by ClusterTruck CEO, Janet Monroe to talk about how ClusterTruck works. They later talk about qualifying and today’s practice with Alex Palou on top and make their predictions. In the fifth segment of the show, they answer live fan questions about the Penske scandal and the hybrid. They are then joined by Dr. Nassar Hanna of IU Health to talk about the Indy 500, lung screening, and the Indy 500 festival. They later talk about what Kevin witnessed when Team Penske was pulled out of the line. To wrap up another edition of the show, they send their thanks to everyone and get settled into race week! See omnystudio.com/listener for privacy information.

You may have become so used to them that you no longer notice, but snaking through downtown Indianapolis' northwest quadrant are the remains of a revolutionary public transit system that transported riders on elevated tracks 30-feet high. It was called the People Mover, developed for $44 million by Clarian Health Partners, the hospital system now known as Indiana University Health. From its launch in 2003 to 2019, it recorded roughly 6 million rider trips on a 1.4-mile track running between Methodist Hospital, University Hospital and Riley Hospital for Children.  The People Mover had the cooperation of city officials, who allowed the track to use public right of way along Senate Avenue, West 11th Street and University Boulevard. And the People Mover was filled with promise, as some predicted it could be expanded to a larger public transit system that would include Indianapolis International Airport. But tram came to screeching halt in 2019, when IU Health said it would begin offering shuttle buses instead and expected to save about $40 million over 10 years. That also was about the time IU Health began planning a massive facility consolidation and modernization project downtown. IBJ reporter Daniel Lee has a personal connection to the People Mover and recently began looking into what remains of the twin-track system and whether IU Health has any plans to resurrect it. In this week's edition of the IBJ Podcast, Lee also gauges support for a proposal that would transform the infrastructure into an elevated trail celebrating the heritage of Black communities on downtown's northwest side.

The IU Motorsports Medicine Fellowship gives trainees a chance to specialize in everything a doctor might see while working with a motorsports team.The program teaches the fellow about high velocity crash injuries, but they also manage primary care and injury prevention for these teams.A fellow is a fully qualified doctor that has completed their required residency training. Working as a fellow is extra subspecialized training that allows better opportunities for a doctor in the future.The team of doctors tackle the obvious, high velocity, and ultra high velocity crash injuries, but they also handle injury prevention and sit on safety panels to reduce serious injuries.IU is increasing the amount of highly specialized motorsports doctors with this program.These doctors work a lot with IndyCar, but get a chance to learn about other motorsports disciplines.The program coordinates with multiple motorsports series, which gives the fellow a chance to travel with the teams and get as much real-world experience as possible.The one-year program starts at the beginning of August, which means it wraps up with the greatest spectacle in racing as one of the final learning opportunities for the fellow.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Inside INdiana Business with Gerry Dick, global innovation arrives in a bigger way in Indiana. Silicon Valley-based Plug and Play is expanding to the new IU Launch Accelerator at 16 Tech, aiming to recruit and grow life sciences startups in Indianapolis and connect them with Warsaw's growing medtech hub. CEO Saeed Amidi says Indiana's combination of university talent and global companies like Eli Lilly makes it a powerful new frontier for innovation. Plus: How the new IU Health incubator at 16 Tech could transform Indianapolis into a national player in biosciences. Roche Diagnostics and Eli Lilly announce major U.S. manufacturing expansions, with the potential for Indiana to land more investment. Community Health Network opens the first phase of its Westfield campus, featuring AI-assisted patient care. A new Ronald McDonald Care Mobile rolls out in Evansville to combat Indiana's high infant and maternal mortality rates. Also in this episode: Ports of Indiana-Mount Vernon launches a new railroad to drive economic development. Terre Haute's Hulman Field Air Base plans a new $13 million small arms training range. Fort Wayne breaks ground on an 8,400-seat soccer stadium ahead of joining USL League One. A Noble County fire department auctions off a pumper truck to fund new equipment. Gaylor Electric becomes the first company to twice win National Contractor of the Year honors. IU Indianapolis expands STEM research space with a new lab building at 16 Tech. Ball State completes a $60 million renovation of Cooper Science Building. Indiana Tech launches a new advanced manufacturing innovation center at Electric Works in Fort Wayne. And: Hud Mellencamp and Hard Truth Distilling launch a new whiskey celebrating Indiana farmers and the Mellencamp legacy. The Pacers surge ahead in the NBA Playoffs as Caitlin Clark and the Indiana Fever prepare for a historic season. Inside INdiana Business previews next week's kickoff of Business at the Brickyard coverage at the Indianapolis Motor Speedway.

This weekend's Newsmaker, Indiana University hepatologist and key opinion leader Naga Chalasani, joins Roger Green to discuss Early Experience with Resmetirom To Treat Metabolic-Associated Steatohepatitis with Fibrosis in a Real-World Setting, an article his group published recently in Hepatology Communications. He shares highlights from the paper and points out the one key area in which his group found room for improvement in their initial protocol. Naga and colleagues wrote this paper after learning from Madrigal Pharmaceuticals that they were among the largest early prescribers of resmetirom and, relative to others, had achieved reimbursement with virtually all their patients and a high percentage of patients actually starting the medication. After receiving requests from other states for advice, the group decided to author this paper.In the paper, Naga and colleagues focused on patient selection, care pathway, how IUHealth got the medicine to their patients, and experience with safety and tolerability.In the paper, Naga and colleagues discuss their experiences in prescribing resmetirom for 113 patients in the first seven months after resmetirom's approval. Of these, IUHealth succeeded in achieving reimbursement for 110 of them. Of these patients, 83 initiated therapy, and 16% of those discontinued. In this interview, Naga shares some of the decisions that made the group so successful in the first three areas and identifies one subsequent area where the group found an opportunity for improvement: systematic follow-up with patients after prescribing. He attributes the 16% discontinuation rate to a "prescribe and forget" policy, similar to one that was successful in HCV, where clinicians prescribed without systematic follow-up until blood levels were obtained three months later. With a "prescribe and follow up" policy that includes phone calls at 1 and 3 months, he anticipates discontinuation rates will fall to something akin to the 5% rate in Phase 3 trials. What makes this interview so fascinating is Naga's description of the thinking that went behind specific decisions the group made in terms of patient management and pathway and suggests other options that might work as well. In all, this interview provides an excellent guide for clinics and providers on how to best integrate resmetirom into their practices.

00:00:00 - Surf's Up: Season 6 Episode 5Host Roger Green briefly describes this episode's three sections and introduces Roundtable guests. The Roundtable panel shares groundbreakers. 00:10:39 - Roundtable: A Deep Dive Into Drug Development, Part OneThe opening portion of this month's roundtable centers around two issues: exciting data for FGF-21s and, more generally, treating patients with cirrhosis. Naim Alkhouri sets the tone in his opening comments, which start by focusing on the exciting SYMMETRY data from efruxifermin and then hones in on FGF-21s and resmetirom in cirrhosis. The rest of the conversation features Jörh Schattenberg, Sven Francque and Naim discussing therapies in development for compensated and decompensating cirrhosis.00;24:44 - Newsmaker: Naga Chalasani on Real-World Experience Prescribing ResmetiromNaga joins Roger to discuss the paper Early Experience with resmetirom to treat Metabolic Dysfunction-Associated Steatohepatitis With Fibrosis in a Real-World Setting from his group at Indiana University, which his group authored and Hepatology Communications recently posted. The paper, based on IU Health's experience with its first 113 resmetirom patients, shares the group's practical experience developing processes to work closely with the specialty pharmacies dispensing resmetirom and, finally, concludes that a more engaged patient management strategy might reduce drug discontinuation to a level comparable with clinical trials.  00:47:21 - Expert: Scott Friedman on Gene Therapy, Diversity of Stellate Cell Types, Other Basic Liver ScienceScott and Roger cover a range of basis science topics in a fast-moving 19-minute discussion. It starts with Scott discussing the increasing acceptance that gene therapy is an acceptable way to treat a range of liver diseases, many of which are orphan or ultra-orphan but, in fact, include potential gene therapies for non-cirrhotic MASH and MASH cirrhosis. He notes that in addition to classic gene therapy, which introduces protective gene variants into the systems of patients with the risky variants, gene therapy is now looking to introduce FGF-21 into patients through genetic modification. From there, the conversation covers CAR-T therapy, the increasing ability to identify many different types of stellate cells and the idea that the most effective therapy for eary fibrosis, advanced fibrosis and cirrhosis might require fundamentally different kinds of interventions. The two final elements are the idea that what we now call "MASH" may be several diseases with different etiologies with similar manifestations and a passionate call for all of us to support maintaining NIH funding in whatever ways we can.01:06:45 - Business ReportAs Roger copes with his laryngitis, AI voices deliver an abbreviated business report 

Voice of the Cardinals Mick Tidrow chats with Director of Athletics Jeff Mitchell, star gymnastic Ashley Szymanski, Mancino's owner Jeff Carrigan, and Dr. Chandler Brobst from IU Health. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Drug shortages continue to pose significant challenges for hospitals and health systems. While they gained national attention during the COVID-19 pandemic, pharmacy departments have managed them for decades. During high-profile shortages, institutions must rapidly establish command centers, engage stakeholders, and implement plans for frontline staff. Once resolved, shortages often recede from immediate focus until the next crisis emerges. However, pharmacy departments consistently manage shortages on a daily basis, often without recognition. Dr. Kyle Hoelting, Sr. Clinical Manager of Drug Information and Drug Shortages at Vizient, Dr. Heather Warhurst, Director of Drug Use Policy, Quality Initiative and Regulatory at IU Health, and Dr. Chris Nagy, Medication Sourcing and Supply Pharmacist at Intermountain Health join us to discuss a Vizient workgroup project designed to measure the impact of drug shortages and highlight the crucial role of pharmacists in their management.   Guest speakers:  Heather Warhurst, Pharm.D, MHA Director of Drug Use Policy, Quality Initiative and Regulatory IU Health   Chris Nagy, Pharm.D, BCPS Medication Sourcing and Supply Pharmacist Intermountain Health   Kyle Holting, Pharm.D, BCPS Senior Clinical Manager of Drug Information Vizient Center for Pharmacy Practice Excellence   Host: Stacy Lauderdale, Pharm.D, BCPS Associate Vice President Vizient Center for Pharmacy Practice Excellence VerifiedRx Host   Show Notes:  [01:18-02:29] Heather and Chris introductions [02:30-04:00] Vizient drug shortage key performance indicators (KPI) workgroup series [04:01-10:04] Labor and Inventory drug shortage KPIs [07:50-16:56] Patient Safety and Stress to Front Line Staff drug shortage KPIs [16:57-18:32] Call to Action   Links | Resources:  Key performance indicators for the management of drug shortages   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Throughout Dr. Jeff Bird's long and fulfilling career in medicine, he has put his patients—and the people of Muncie—first. Dr. Bird grew up in Muncie. After completing his residency at Ball Hospital, he embarked upon a long and fulfilling career in medicine here in his hometown. As the hospital prepares to celebrate its 100th anniversary, Dr. Bird reflects on the decades he's spent—first as a doctor and then as an administrator—working to provide the best healthcare to the people who live and work in East Central Indiana. Since 2017, Dr. Bird has served as the president of the East Central Indiana region for IU Health, which includes IU Health Ball Memorial and Blackford Hospitals. Prior to assuming this executive role, Dr. Bird served 14 years as the associate director of the Ball Memorial Hospital Family Medicine Residency Program. Before that, he was the owner of a thriving private practice of family medicine. In this episode, Dr. Bird talks about his great passion for medicine and his great love for Muncie. He also shares why he feels compelled to give back to the community that raised him along with his reasons for feeling—in his own words—“bullish” about the future success of the city and the region.If you enjoy this episode, please leave a review to support the show 

Send us a textIn this episode we welcome Dr. Na Tosha Gatson, Director of Neuro-Oncology & Professor of Neurology and Medicine at IU Health. A leader in the field, Dr. Gatson shares insights on advancements in neuro-oncology, the impact of brain tumors on women's health, addressing health disparities, and the importance of quality-of-life care. Support the show

Residents in Fishers have watched construction begin and continue over the past few years, dubbed the Fishers Community Impact Project due to its scope both on and off campus - but most projects will come to completion in 2025. The $300 million project began in 2018 with conversations involving planning and design, but it would be another four years before breaking ground. “Our intentions were to get the ball rolling in 2020, but the pandemic pushed back our timeline so we could focus on caring for immediate needs,” said Senior Project Manager Carl Zenor. “It did allow us to get the details ironed out and make sure we were giving patients what they need.” Those needs were determined by evaluating the market and asking Fishers residents what they were missing from their local hospital. “Many residents were leaving Fishers for certain services,” said Chief Operating Officer Soula Banich. “We identified those additional service lines that were needed, and the campus will go from 50 beds to 88 beds.” In order to expand current services such as their cardiovascular care, gastroenterology, orthopedics, general medicine, general surgery, and primary care, as well as obstetrics and gynecology, ear, nose and throat, nephrology, neurology, and pulmonology, the footprint of the hospital will double.

Your day ahead forecast (COLD), "stay off the ice," snowy road improvements, IU Health breach, wildfires in LA, META drops fact checkers, future of Ryan Kelly, retired Girl Scout cookies and more...See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Jenn Alvey, CFO of Indiana University Health, joins the podcast to discuss key trends shaping healthcare, including labor shortages, inflationary pressures, and the transformative potential of AI. She also highlights IU Health's innovative affordability plan and ambitious growth initiatives, providing valuable perspectives on how the organization is expanding and enhancing care for Indiana's communities.

In this special supersized episode, Ron Stiver, President of IU Health's System Health Solutions business, sits down with physicians Dr. Mike Teague and Dr. Albert Chamberlain located in the southern region of the state for an in-depth discussion on the impact of innovative primary care models on patient wellbeing.

One way you can gauge the health of a city is the number of cranes on its skyline. One of the biggest contributors of cranes over downtown in the last two years has been the $4.3 billion IU Health hospital campus under construction just south of Methodist Hospital. It's a generational development for that side of downtown, but IU Health officials want to make sure it doesn't overshadow the many needs of historic neighborhoods to the north and to the west. For several years the hospital system has been planning an initiative and nonprofit organization known Indy Health District. It focuses on five neighborhoods with a total of about 9,000 residents who, due to a number of socio-economic factors, have a much lower life expectancy than folks who live in other parts if the Indy metropolitan area. The district's leaders want to find solutions for most, if not all, of the issues weighing on these neighbors, including housing, transportation, land use, safety and food deserts. It's an incredibly ambitious undertaking that's a bit difficult to wrap your brain around. It also prompts a healthy amount of skepticism. So we've invited Jamal Smith to lay out the plans for us. He's executive director of Indy Health District and executive director of government affairs and strategic partnerships for IU Health. And he grew up with some of the impediments to success and good health that the residents of the district face. The IBJ Podcast is brought to you by Taft.  

In episode 79 of the Summits Podcast, Vince Todd, Jr. is joined by Teresa Altemeyer, cancer survivor and patient advocate through cancer support groups and art therapy at the CompleteLife Program at IU Health and the IU Simon Cancer Center. Tune in as Teresa shares the incredibly important role that these groups and therapies play for patients, survivors and caregivers. The Heroes Foundation proudly provides funding to the CompleteLife Program to further our mission to provide meaningful support to cancer patients, education to promote cancer prevention and resources to advance research for a cure.

Congrats to another Taylor Swift concert ticket winner!! Brittany lives downtown and works as a nurse at IU Health in Carmel. She was working together with 8 other nurses so she has no idea who she's gonna take to the show with her!! Smileys Secret Sound this time was sequins being sewn into clothes!?!? See omnystudio.com/listener for privacy information.

Lizett Itai Cortes Perez dedicates her career to bridging the gap between healthcare providers and patients through precise and empathetic translation.Perez's journey with IU Health began four months ago when she recognized the vital need for more interpreters in the healthcare system.She is laser-focused on ensuring patients feel heard, understood, and empowered to make informed decisions about their health. She notes the need for more skilled interpreters only grows more pressing.Perez's contributions extend far beyond her work as an interpreter. She also uses her creative talents to design and decorate stunning evening gowns for the annual “Dia de Muertos celebration.”Perez recently became a U.S. citizen this past August after years of navigating the complexities of the immigration system.Perez will make her second appearance in the Catrina Parade, donning her latest Day of the Dead gown, at The Eiteljorg Museum on Oct. 26 from 10 a.m. to 7 p.m. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Brian Shockney, Senior Vice President of System Regional Operations at IU Health, discusses key healthcare trends, including workforce challenges, the use of AI to enhance operational efficiency, and the vital role nonprofit healthcare systems play in their communities. Brian also shares insights into the future of nonprofit healthcare and its impact on addressing social determinants of health.

Indiana AG Todd Rokita dropped his lawsuit against IU Health over privacy of Ohio girl who traveled for an abortion.  Special Judge Frances Gull ruled to deny a motion to throw out key evidence in the Delphi Murders case.  Plus, a phone repairman in Oklahoma was arrested after he sent himself an EXPLICIT VIDEO from a female customer's phone while he was fixing it.See omnystudio.com/listener for privacy information.

The proposed 2025 Indianapolis budget includes a lot of things – like traffic safety, gun violence and housing – and totals more than $1.6 billion. A county judge says a new Indiana law banning local governments from suing gun manufacturers and sellers cannot apply to an ongoing case involving the city of Gary. Just more than two weeks after amending a patient privacy lawsuit against IU Health, the Indiana attorney general's office filed to dismiss it. Mayor Joe Hogsett addressed recent reports of sexual harassment and misconduct from his former chief of staff at Monday night's City-County Council meeting. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. Today's episode of WFYI News Now was produced by Drew Daudelin and Abriana Herron, with support from News Director Sarah Neal-Estes.

During IU Health Physicians 2024 August Annual Appreciation week, the podcast is recognizing leaders and team members who are excelling at promoting team member engagement and living IU Health Values.

President of IU Health, Brian Bauer joined Fort Wayne's Morning News with Kayla Blakeslee to talk about the new $450 million dollar hospital. See omnystudio.com/listener for privacy information.

Host Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, and marketing colleague, Alan Sardana, chat with Dr. Emily Webber, CMIO at IU Health and Riley Children's Health, about "Mastering AI Governance, Harnessing Listening as a Superpower, Bridging the Tech and Healthcare Cultures, and more." Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Carol Howard is the Executive Director of Rev Indy   Listen to this promo release episode where you'll hear Carol tell us about… ● Rev Indy on May 4th brings together food, fun, and a night of celebration to kick off the greatest month in racing, the impact the event has across Indiana inlcuding care for the drivers and patrons at IMS, and some of the featured guests and special apperances at this year's event ● How her entire childhood was spent in a pool as a comptetive swimmer and was so dedicated to swimming that eventually led her to the Olympic trials in 1996 ● Having a stint of unemployment for the first time in her life was a very humbling experience that helped realign her purpose and launched a new direction in her life, finding the impact that relationships have on professional and personal stories   As always, don't forget to check out our partners and sponsors: St. Elmo Steakhouse, IU Indy Jags, Java House, Migration Wealth Management, AP Engineering and Consulting, This is North Indy, and our recording venue The Hangar Indy. CCS Podcast Partners: ● IU Indy Jags: https://iupuijags.com/ ● St Elmo Steakhouse: https://www.stelmos.com/ ● The Hangar: https://hangarindy.com/ ● This is North Indy: https://linktr.ee/ThisisNorthIndy ● Java House: https://javahouse.com/ ● Migration Wealth Management: https://migrationwealthmanagement.com/ ● AP Engineering and Consulting: https://www.apecindy.com/ Connect with CCS hosts: ● Connect with Jason: https://lnkd.in/dS82puKp ● Connect with Drew: https://lnkd.in/d-VtF9Hb ● Connect with Matt Hadley: https://lnkd.in/dhAhM36A ● Connect with Matt Carroll: https://lnkd.in/dkv7VmDx

“Sterile Processing, what's that?” If this question sounds all too familiar, you're not alone! As Sterile Processing professionals, we've all been asked this a time or two. So, how do you describe our career? How should we describe it? On this episode of Beyond Clean Season 24, "The Papers that Make Us Awesome," we're joined by Beth Rayfield, the trailblazing Director of Central Supply and Sterile Processing at IU Health, to uncover the secrets of crafting job descriptions that don't just fill roles but forge an unstoppable team of Sterile Processing heroes. We're not just talking about duties and qualifications; we're diving into how the right words can attract top talent, set the stage for exceptional careers, and ultimately, redefine what it means to be a #CleanFreak. Tune in, get inspired, and let's rewrite the rules of SPD success, one job description at a time! Season 24 of Beyond Clean releases under the 1 Episode = 1 CE delivery model. After finishing this interview, earn your 1 CE credit immediately by passing the short quiz linked below each week. Visit our CE Credit Hub at beyondcleanmedia.com/ce-credit-hub to access this quiz and over 350 other free CE credits.  #BeyondClean #SterileProcessing #WeFightDirty

On this episode of Gone Boss we talk with Heather Wallace, Medical Oncology RN at IU Health. 

Broadband Initiatives in Indiana Indiana is working to closing the gap on the digital dive. We'll look at how $1.5 billion in public-private funding is connecting unserved or underserved Hoosiers to the web. NFL Combine-IU Health's Medical Role Indianapolis is hosting its 37 th NFL Combine and IU Health is playing a major role in making sure the players are in top shape. Learn why the medical component of the Combine is a major reason why Indy continues to host the event. Ports of Indiana Indiana's three ports shipped 12.6 million tons of goods last year, the second highest in its 63-year history. We'll have more on the surprising numbers of a state many consider to be landlocked. Indiana Agriculture-Cuba Hoosier-grown food is gaining traction on the international stage, specifically in Cuba. We'll break down Indiana's global ag strategy and what it means for the state's farmers.

Alejandro Mayorkas says he bears no responsibility for the broken border. Shreve is running for Congress. Couldn't win in Indianapolis, who is his team for this race? Why is he running? Will Biden fire AG Merrick Garland? Trump asks where Nikki Haley's husband is. He's serving in the military. It's a weird thing to say. Weird, and dumb. But what about this comment about NATO and Russia? Sec. Def. Lloyd Austin again in a hospital I hope he's ok, but I now wonder if his health issue was never fully shared with America. Proof of Concept: Challenge all Squad members. Challenge all Bigots. Israeli hostages rescued in Gaza. Shreve is running for Congress.  AlaskaPox. It's a thing.  Biden discussing the size of ice cream containers. Businesses are the enemy. Biden: “Greedy businesses” Do they not want us growing our own food? These people cannot be trusted and should not be listened to. Sen Koons laughable comments about how sharp Biden is. Jill Biden, caretaker for Joe, is yelling at us for noticing her husband is incapable of being president, and does Hillary really think that she's the heir apparent? GOP Rep. Mike Gallagher announces retirement from House: 'Congress is no place to grow old' Gerry Dick from Inside Indiana Business talking about this weekend's All-Star games.  Scandals at Newfields, IU Health? Fill up on the News. What commercials worked on the Super Bowl and what didn't? Robert Kennedy Jr apologizes for ad on Super Bowl. Sec Def Austin back in the hospital. This time everyone was notified. Boston mayor wants outlying communities to take on the illegal migrants.  Senator Murphy wants Israeli aid to have strings attached.  See omnystudio.com/listener for privacy information.

IU Health's CEO on Prioritizing Consumer Experience Season 10 kicks off with Dennis Murphy, President and CEO of Indiana University Health. Dennis shares what senior hospital leaders can do to keep making progress with consumer experience when they have so many other priorities, then he provides some details about an exciting new hospital that IU Health is developing in downtown Indianapolis and how patient experience is being prioritized as part of the building.  All that, plus the Flava of the Week about Kroger piloting new primary care clinics for seniors. What's Kroger's formula for success among underserved Medicare populations, and how can grocery brands play a greater role in consumers' health and wellness?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Season 10 kicks off with Dennis Murphy, President and CEO of Indiana University Health. Dennis shares what senior hospital leaders can do to keep making progress with consumer experience when they have so many other priorities, then he provides some details about an exciting new hospital that IU Health is developing in downtown Indianapolis and how patient experience is being prioritized as part of the building.  All that, plus the Flava of the Week about Kroger piloting new primary care clinics for seniors. What's Kroger's formula for success among underserved Medicare populations, and how can grocery brands play a greater role in consumers' health and wellness?  This show is produced by Shift Forward Health, the consumer advisory firm that partners with you to operationalize consumer-first health. (#302) See omnystudio.com/listener for privacy information.

LLMs are great with text but struggle with extensive structured data and expressing insights about it. In this podcast episode, Steven Wasick, the founder and CEO of infoSentience, introduces their AI platform and how it's already impacting healthcare by turning vast datasets into human-like narratives, thus providing valuable insights. Unlike general generative AI, infoSentience specializes in handling large structured datasets, offering a unique solution for organizations overwhelmed by data. Steven explains how infoSentience collaborates with IU Health to automate doctor bios, ensuring continuous updates for accuracy and time savings. He also shares how the platform's versatility extends to sports, with CBS Sports and the Chicago Mercantile Exchange, providing customized reports and adopting a journalistic approach as it weaves key moments into compelling stories. Tune in to learn how infoSentience's innovative AI platform transforms data into actionable insights, revolutionizing the approach to data analysis! Resources:  Connect with and follow Steven Wasick on LinkedIn.  Learn more about infoSentience on their LinkedIn and website. Listen to Steven's previous interview on the podcast here.

Two more Board of Trustees members at Newfields have stepped down. Five Board of Trustees members have now resigned since President and CEO Colette Burnette's departure. Indiana Republican Congressman Jim Banks might have an opponent on the ballot for next year's U.S. Senate primary. Brandon Smith reports a judge ruled in favor of southern Indiana egg farmer John Rust Thursday, in a lawsuit challenging the state's ballot access law. Indiana researchers have unveiled a statewide evictions and foreclosures dashboard, believed to be the first of its kind in the country. Nurses at IU Health's University and Methodist hospitals say they're planning to unionize. More high schools than ever offer students the chance to earn college credit - at one Indianapolis charter school, that's the entire focus. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. Today's episode of WFYI News Now was produced by Darian Benson, Abriana Herron, Drew Daudelin and Kendall Antron with support from Sarah Neal-Estes.

In this episode of Major Choices,  Career Development Center career coaches, Caitlyn & Nikki, explore the topic of building community through networking. They share  tips on how to network effectively, how to build trust and rapport with people, and how to leverage your network to create opportunities.In the second half of the podcast we are bringing back the Inside Scoop, a segment where career coach, Rachel, interviews a professional to learn about the world of work. In this episode Rachel talks with Katherine Boeck, a medical social worker from IU Health.

I have been an operations pharmacist at Riley for 7 years and have completed IU Health's non-traditional pharmacy residency.  In addition to working in the main pharmacy, I rotate providing evening clinical services to our emergency department, cover Peds/PICU and NICU clinical services at IU Health North, and also provide clinical pharmacy services for our maternity patients in the Riley Maternity tower.  Outside of Riley, I am a member of the Pediatric Pharmacy Association and am a peer-reviewer for the Journal of Pediatric Pharmacology and Therapeutics.  Outside of work, my interests include gardening, trying new restaurants, and going to see live comedy shows.

Alex Choi has been involved in various professional pursuits since graduating. He joined a consulting company and worked as a research associate before moving back home to Indiana to pursue medical school. Alex obtained a master's in biology and physiology to secure admission to Indiana University School of Medicine. He met his wife in the second year of med school and they have two children. After medical school, Choi joined a private practice in Indianapolis, where he became the managing partner and president of the Anesthesia Consultants of Indianapolis. Alex also received a master's in public health and policy management, which helped him become more involved in public policy issues. He was the physician leader for the division at IU Health until last year when he stepped down to go into pre-retirement.  Alex left IU Health and joined another surgery center practice and was asked to be the Indiana Medical Director for the organization. He has been involved in various organizations, including the national society and state societies of organized medicine. He was diagnosed with bipolar disorder over a decade ago and has since recovered from it. This inspired Alex to partner with people who formed the Zionsville Alliance for Mental Wellness Exam, a nonprofit that helps people navigate the mental health network system. He talks about his experiences in police and has been involved in public policy, working on the transition team for governors and serving on the Zionsville Town Council. However, he decided not to run for reelection to focus on his family and watch his children grow up. Misconceptions about Bipolar Disorder Alex discusses the challenges and misconceptions about bipolar disorder, a mental health issue that is a spectrum. He emphasizes the importance of not stigmatizing anyone with bipolar disorder or any mental health issues. Alex shares his own experiences with rapidly cycling episodes of mania and depression, which can last months, weeks, or months. He emphasizes the need for support networks and the importance of understanding that bipolar disorder is a chronic illness that can be overcome with the right therapy, support, and medications. He has been open about his journey and has used his town council status to put messages out about mental health treatment for mental health disorders. His openness has encouraged others to seek help.  A Governor's Role in Healthcare Alex has also worked on the healthcare transition team for two different governors and a new mayor. In the governors' case, he helped determine healthcare priorities for the state, discussing data and determining priorities. He had a one-sheet agenda and an open forum for discussing these topics. In the mayor's role, he became involved in the town's finances, overseeing the town's finances and overseeing the city's budget. The governor oversees the Department of Health and public health systems, which are interconnected and heavily influenced by Medicaid. In Indiana, the Medicaid system is administered by the governor's office through the Family and Social Services Administration, providing a safety net for those suffering from chronic illnesses or those unable to afford health care due to income or special status. As an unpaid lobbyist, Alex was involved in lobbying state representatives and advocating for better health care in Indiana. He ran for a state representative in a caucus election in 2015. Alex talks about why he wanted to be a state legislator and his efforts in that area, including pushing for the licensure of anesthesiologist assistants, a group of advanced providers, and establishing a program that graduates 24 anesthesiologist assistants annually to address shortages and anesthesia in the state. He talks about medical liability insurance in Indiana, and lobbying from the Trial Lawyers Association which led to increased limits on liability insurance costs. Despite these challenges, Alex believes that the state has made progress in improving healthcare policies and addressing the challenges faced by physicians and patients in Indiana. Expanding the Potential of Nurse Practitioners and Physician Assistants Alex discusses the potential of nurse practitioners and physician assistants to perform additional procedures that current regulations prohibit. He acknowledges that these areas vary from state to state, and medical schools and residencies must adhere to strict guidelines. However, he believes that there is higher variability in what is taught in medical schools and residencies, which can lead to a lack of qualified clinicians. He believes that medical schools and residencies will continue to train physicians to more complex procedures and specialties, leading to a shortage of doctors for certain procedures or patient types. As a result, physicians will need to push towards greater involvement from nurses and physician assistants but also ensure proper oversight.    Running a Political Campaign Alex talks about what he learned when running a campaign, which involves getting people to believe in oneself and their views. He found it challenging to run for office due to his full-time job and campaigning, but also appreciated the support of his family and friends. During his campaign, he faced opposition from the General Assembly, which passed one of the harshest anti-abortion laws after the DODDS decision. He had to navigate the public reaction and find a balance between advocating for pro-choice and expressing different views within a party.    Influential Harvard Professors and Courses Alex shares his personal and professional experiences with several courses and professors. He attended a church near his freshman year and was an usher. While there, he found the sermons of Professor Gomes helpful and realized the importance of his involvement in student lives.    Timestamps: 04:46 Bipolar disorder, treatment, and advocacy 12:14 Mental health treatment and government policy 18:52 Healthcare policy and legislation in Indiana 31:34 Medical professional scope of practice and campaign lessons learned 39:03 Mental health, politics, and career with former Indiana state senate candidate   Links: Facebook: https://www.facebook.com/aschoi/ LinkedIn: https://www.linkedin.com/in/alexander-choi-a4005b47/   CONTACT:  Email:alexander_choi@yahoo.com  

Ron Stiver sits down with Greg Kiray, MD (Chief Medical Officer, System Health Solutions) and Paul Calkins, MD (vice president and Chief Quality Officer, IU Health) for an in-depth look into our culture of safety. Hear about this year's survey findings, key areas of progress in SHS, and the newly implemented tiered huddles.

While there is ample talk of the use of AI (and Generative AI) in healthcare, sometimes there is a lot of confusion as to which solution is better. In this episode, hosts Reed Smith and Chris Boyer discuss the two different “worlds” of AI - open vs. closed systems, outlining use cases in healthcare for both and asking which is better for health systems. Then, Jeremy Rogers of IU Health joins and shares the journey he and his organization are taking with the adoption and acceptance fo AI - in both front and back of house applications.  Mentions from the Show: Should You Be Blocking ChatGPT's Web Crawler? CNN, Disney, Reuters, and the New York Times Already Are Two Worlds of Generative AI: Closed Source AGI vs. Open Source Narrow AI Deep learning tools for advancing drug discovery and development Artificial intelligence in public health: the potential of epidemic early warning systems Jeremy Rogers on LinkedIn IU Health Find a Provider directory Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of “This Is Purdue,” we're talking to Michele Buzon, professor of anthropology in Purdue University's College of Liberal Arts.  This marks the final episode in our 2023 Purdue Research Series, which shares how Purdue provides practical solutions to the world's toughest challenges.   As a bioarchaeologist, Michele's examination of skeletal remains can help us better understand the lives of everyday people who lived thousands of years ago. She and her team conduct research along the banks of the Nile River Valley in Tombos, Sudan, exploring what life was like in ancient Nubia — and why that still matters today.  Although Michele's work explores the past, collaboration with researchers like Dr. Randall Loder at IU Health is helping her better understand present-day medical conditions like CAM lesions, an injury on the femur that has been found in young athletes. Previously thought to be a modern issue exclusive to athletes, Michele discusses how she and Dr. Loder found evidence of its existence in the ancient communities she studies.  Hear how Michele's work brings many different people and disciplines together as she and her team look to better understand the past, from relationship-building with the local community in Sudan to analyzing finds.  

Steve Wasick has more than a decade of experience in the Generative AI space as CEO, working with companies like MaxPreps, Scientist.com, IU Health, and many others. He was the Technical Editor for the book Enterprise AI for Dummies and graduated magna cum laude from Northwestern University Pritzker School of Law.Advertisers:https://www.cynomi.com/how-to-add-vciso-services/https://supportadventure.com/MSPRadio/Do you want the show on your podcast app or the written versions of the stories? Subscribe to the Business of Tech: https://www.businessof.tech/subscribe/Support the show on Patreon: https://patreon.com/mspradio/Want our stuff? Cool Merch? Wear “Why Do We Care?” - Visit https://mspradio.myspreadshop.comFollow us on:Facebook: https://www.facebook.com/mspradionews/Twitter: https://twitter.com/mspradionews/Instagram: https://www.instagram.com/mspradio/LinkedIn: https://www.linkedin.com/company/28908079/

The use of Generative AI is a contentious issue across many industries, including sports. We spoke with AI expert Steve Wasick for his views on the present realities of AI and where the future of this revolutionary tech is going: What role can we expect AI to play in the future of sports? Why is Generative AI so controversial – what is it exactly and why the concern? How is Generative AI changing and benefiting the sports community? What fans don't realize is AI? Steve has more than a decade of experience in the Generative AI space working with companies like MaxPreps, the Chicago Mercantile Exchange, IU Health, and many others. As Founder of infoSentience, his company uses AI to provide millions of automated articles to CBS Sports, ranging from fantasy game recaps to live coverage of the NBA and NFL. Steve was the Technical Editor for the book Enterprise AI for Dummies and graduated magna cum laude from Northwestern University Pritzker School of Law. ---- Subscribe to the Sports Tech Feed newsletter. Your source for in-depth sports technology insights, news, and analysis: https://sportstechfeed.substack.com

Producer's Note: During the summer months we'll be re-releasing some of our favorite episodes for our "Summer Encore Series." This episode originally dropped on November 12, 2019, and we loved the creative way in which IU Health immersed themselves in the patient's journey. Please note that some details and situations described in the episode may not neccessarily be the same as when it originally was released. Immersive experiences can be a powerful tool to demonstrate the customer experience, but for patients at a hospital, it can be impactful – and emotional – for the leadership of an organization. Guest host Pat Gibbons welcomes guest Karen Cernock from Indiana University Health to discuss how an immersive experience for their board developed into a program throughout the organization. Read the original episode's show notes page here: https://cxleaderpodcast.com/wear-comfortable-shoes/ Listen to more podcasts at https://cxleaderpodcast.com/ Learn more about Walker at https://walkerinfo.com/ 

This episode features Jim Mladucky, Vice President of Design and Construction at IU Health. Here, he discusses his plans for the creation of a health and science campus, and more.

Indiana University Health Foundation invites you to kick off the greatest month in racing at Rev, presented by Fifth Third Bank and hosted at the Indianapolis Motor Speedway. 2023 celebrates our event's 10th year, which will take place this Saturday! Listen to the Smiley Morning Show chat with REV executive director, Carol Howard!See omnystudio.com/listener for privacy information.

Carol knows how to throw a badass party! And her parties raise millions for Indianapolis nonprofit organizations. In this episode, we talked about her career - including working at Motorola executing their sponsorships of Vans Warped Tour, X Games and their motorsports sponsorship of Michael Andretti. In 2018, she directed the Universal Studios UK Movie Premiere “Born Racer” held at Indianapolis State Museum. She directed the Premiere and coordinated the pre-event cocktail reception, red carpet, media, and photo opportunities with Universal Studios. One year later, she planned and managed a press conference and trailer premiere for the “Ford vs. Ferrari” movie, attended by Academy Award-winning actors Matt Damon and Christian Bale, at the Indianapolis Motor Speedway. She has an amazing career, but her favorite job is being a mother to three strong and resilient girls. She opened up about a difficult pregnancy with her twins - if she delivered full term, all three of them would've died due to a very dangerous infection in Carol's placenta. She credits IU Health to saving their lives and providing her the best care the weeks and months ahead of her delivery. For that, Rev has become her labor of love and her way of giving back to the hospital. We talked about feeling vulnerable, finding joy, the things that really matter to her, and what has led to her success. Tune in to hear about Carol's friend Ashley Judd and the "crappy" ending for her first pair of designer sunglasses. Learn more about Rev: https://revindy.org/